The search for an HIV cure: tackling latent infection

Stephen J Kent, Jeanette C Reece, Janka Petravic, Alexey Martyushev, Marit Kramski, Robert De Rose, David A Cooper, Anthony D Kelleher, Sean Emery, Paul Urquhart Cameron, Sharon R Lewin, Miles Davenport

Research output: Contribution to journalArticleResearchpeer-review

48 Citations (Scopus)

Abstract

Strategies to eliminate infectious HIV that persists despite present treatments and with the potential to cure HIV infection are of great interest. One patient seems to have been cured of HIV infection after receiving a bone marrow transplant with cells resistant to the virus, although this strategy is not viable for large numbers of infected people. Several clinical trials are underway in which drugs are being used to activate cells that harbour latent HIV. In a recent study, investigators showed that activation of latent HIV infection in patients on antiretroviral therapy could be achieved with a single dose of vorinostat, a licensed anticancer drug that inhibits histone deacetylase. Although far from a cure, such studies provide some guidance towards the logical next steps for research. Clinical studies that use a longer duration of drug dosing, alternative agents, combination approaches, gene therapy, and immune-modulation approaches are all underway.
Original languageEnglish
Pages (from-to)614 - 621
Number of pages8
JournalLancet Infectious Diseases
Volume13
Issue number7
DOIs
Publication statusPublished - 2013

Cite this

Kent, S. J., Reece, J. C., Petravic, J., Martyushev, A., Kramski, M., De Rose, R., ... Davenport, M. (2013). The search for an HIV cure: tackling latent infection. Lancet Infectious Diseases, 13(7), 614 - 621. https://doi.org/10.1016/S1473-3099(13)70043-4
Kent, Stephen J ; Reece, Jeanette C ; Petravic, Janka ; Martyushev, Alexey ; Kramski, Marit ; De Rose, Robert ; Cooper, David A ; Kelleher, Anthony D ; Emery, Sean ; Cameron, Paul Urquhart ; Lewin, Sharon R ; Davenport, Miles. / The search for an HIV cure: tackling latent infection. In: Lancet Infectious Diseases. 2013 ; Vol. 13, No. 7. pp. 614 - 621.
@article{fcf3c7128d8f4e22acac1f05ac61ecd1,
title = "The search for an HIV cure: tackling latent infection",
abstract = "Strategies to eliminate infectious HIV that persists despite present treatments and with the potential to cure HIV infection are of great interest. One patient seems to have been cured of HIV infection after receiving a bone marrow transplant with cells resistant to the virus, although this strategy is not viable for large numbers of infected people. Several clinical trials are underway in which drugs are being used to activate cells that harbour latent HIV. In a recent study, investigators showed that activation of latent HIV infection in patients on antiretroviral therapy could be achieved with a single dose of vorinostat, a licensed anticancer drug that inhibits histone deacetylase. Although far from a cure, such studies provide some guidance towards the logical next steps for research. Clinical studies that use a longer duration of drug dosing, alternative agents, combination approaches, gene therapy, and immune-modulation approaches are all underway.",
author = "Kent, {Stephen J} and Reece, {Jeanette C} and Janka Petravic and Alexey Martyushev and Marit Kramski and {De Rose}, Robert and Cooper, {David A} and Kelleher, {Anthony D} and Sean Emery and Cameron, {Paul Urquhart} and Lewin, {Sharon R} and Miles Davenport",
year = "2013",
doi = "10.1016/S1473-3099(13)70043-4",
language = "English",
volume = "13",
pages = "614 -- 621",
journal = "Lancet Infectious Diseases",
issn = "1473-3099",
publisher = "Elsevier",
number = "7",

}

Kent, SJ, Reece, JC, Petravic, J, Martyushev, A, Kramski, M, De Rose, R, Cooper, DA, Kelleher, AD, Emery, S, Cameron, PU, Lewin, SR & Davenport, M 2013, 'The search for an HIV cure: tackling latent infection', Lancet Infectious Diseases, vol. 13, no. 7, pp. 614 - 621. https://doi.org/10.1016/S1473-3099(13)70043-4

The search for an HIV cure: tackling latent infection. / Kent, Stephen J; Reece, Jeanette C; Petravic, Janka; Martyushev, Alexey; Kramski, Marit; De Rose, Robert; Cooper, David A; Kelleher, Anthony D; Emery, Sean; Cameron, Paul Urquhart; Lewin, Sharon R; Davenport, Miles.

In: Lancet Infectious Diseases, Vol. 13, No. 7, 2013, p. 614 - 621.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - The search for an HIV cure: tackling latent infection

AU - Kent, Stephen J

AU - Reece, Jeanette C

AU - Petravic, Janka

AU - Martyushev, Alexey

AU - Kramski, Marit

AU - De Rose, Robert

AU - Cooper, David A

AU - Kelleher, Anthony D

AU - Emery, Sean

AU - Cameron, Paul Urquhart

AU - Lewin, Sharon R

AU - Davenport, Miles

PY - 2013

Y1 - 2013

N2 - Strategies to eliminate infectious HIV that persists despite present treatments and with the potential to cure HIV infection are of great interest. One patient seems to have been cured of HIV infection after receiving a bone marrow transplant with cells resistant to the virus, although this strategy is not viable for large numbers of infected people. Several clinical trials are underway in which drugs are being used to activate cells that harbour latent HIV. In a recent study, investigators showed that activation of latent HIV infection in patients on antiretroviral therapy could be achieved with a single dose of vorinostat, a licensed anticancer drug that inhibits histone deacetylase. Although far from a cure, such studies provide some guidance towards the logical next steps for research. Clinical studies that use a longer duration of drug dosing, alternative agents, combination approaches, gene therapy, and immune-modulation approaches are all underway.

AB - Strategies to eliminate infectious HIV that persists despite present treatments and with the potential to cure HIV infection are of great interest. One patient seems to have been cured of HIV infection after receiving a bone marrow transplant with cells resistant to the virus, although this strategy is not viable for large numbers of infected people. Several clinical trials are underway in which drugs are being used to activate cells that harbour latent HIV. In a recent study, investigators showed that activation of latent HIV infection in patients on antiretroviral therapy could be achieved with a single dose of vorinostat, a licensed anticancer drug that inhibits histone deacetylase. Although far from a cure, such studies provide some guidance towards the logical next steps for research. Clinical studies that use a longer duration of drug dosing, alternative agents, combination approaches, gene therapy, and immune-modulation approaches are all underway.

UR - http://www.sciencedirect.com/science/article/pii/S1473309913700434

U2 - 10.1016/S1473-3099(13)70043-4

DO - 10.1016/S1473-3099(13)70043-4

M3 - Article

VL - 13

SP - 614

EP - 621

JO - Lancet Infectious Diseases

JF - Lancet Infectious Diseases

SN - 1473-3099

IS - 7

ER -